Document is current
Any future updates will be listed below
-
Authors
Riise, Hilde K.R.
Haugstvedt, Anne
Igland, Jannicke
Graue, Marit
Søfteland, Eirik
Hermann, Monica
Carlsson, Sofia
Skinner, Timothy C.
Åsvold, Bjørn Olav
Iversen, Marjolein M.
-
Funding
Funding for this research was provided by:
Western Norway University Of Applied Sciences
- License Information
-
More Information
Article History
Received: 4 September 2024
Accepted: 4 February 2025
First Online: 19 February 2025
Declarations
:
: This study was approved by the Regional Committees for Medical Research and Health Research Ethics in Norway (74975) and the Norwegian Centre for Research Data (150393). All participants gave informed consent.
: Not applicable.
: Anne Haugstvedt has received lecture honoraria from Novo Nordisk and Abbott. Eirik Søfteland has received lecture honoraria from the following companies within the last five years: Astra Zeneca, Boehringer Ingelheim, Otsuka Pharma, Novo Nordisk, Eli Lilly. The other authors have no conflict of interest to declare.
